Last 47 quarters of trend data · Healthcare · Metabolic & Cardiovascular Biotech
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.18 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.08 | 0.33 | 0.23 | 0.31 | 0.05 | 0.04 | 0.04 | 0.10 | 0.18 | 0.14 | 0.22 | 0.25 | 2.99 | 5.71 | 10.75 | 11.26 | 5.97 | 9.44 | 19.64 | 17.96 | 22.28 |
| — | +651.8% | +449.9% | +224.4% | -73.2% | -68.0% | -81.1% | -61.1% | -93.9% | -97.6% | -97.9% | -97.8% | -49.9% | -39.5% | -45.2% | -37.3% | -73.2% | -53.5% | +8.1% | -1.3% | +32.8% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -64.2% | -20.4% | -12.8% | -27.6% | -9.5% | -13.3% | -6.6% | -18.5% | -12.7% | -9.1% | -9.6% | -13.7% | -11.3% | -14.1% | -14.4% | -18.1% | -29.3% | -16.6% | -22.4% | -21.9% | -18.7% |
| — | -53.0% | -93.2% | -49.6% | +24.6% | -46.3% | +30.5% | -34.7% | -12.2% | +35.5% | +33.5% | +24.3% | +61.5% | +14.7% | +35.7% | +17.2% | -57.3% | +3.4% | -22.1% | -4.0% | -53.4% | |
| ROA | -55.5% | -15.9% | -11.0% | -24.0% | -8.5% | -12.0% | -5.9% | -16.3% | -11.2% | -8.0% | -8.2% | -11.8% | -9.5% | -11.4% | -11.7% | -14.1% | -24.1% | -13.9% | -18.4% | -18.4% | -16.0% |
| — | -32.4% | -85.6% | -47.3% | +23.9% | -49.2% | +27.5% | -38.3% | -17.1% | +29.2% | +29.9% | +16.6% | +60.4% | +18.3% | +36.5% | +23.5% | -50.8% | +6.8% | -16.4% | -0.7% | -44.3% | |
| ROIC | -54.4% | -18.8% | -12.7% | -16.5% | -10.0% | -11.4% | -8.0% | -12.1% | -16.2% | -8.7% | -9.5% | -12.9% | -9.3% | -14.1% | -13.7% | -15.7% | -26.3% | -14.1% | -18.8% | -18.0% | -16.4% |
| — | -64.2% | -59.3% | -36.7% | +38.0% | -31.8% | +16.1% | +6.3% | -73.3% | +38.6% | +30.6% | +17.8% | +64.6% | -0.2% | +27.1% | +13.0% | -60.8% | +13.7% | -6.0% | +13.2% | -32.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | 0.01 | — | — | — | — | — | — | — | — | — | 0.00 | — | — | — | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| — | — | — | — | — | — | — | — | — | — | — | -81.6% | — | — | — | +113.3% | -22.3% | -8.4% | +40.5% | +53.5% | +58.0% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 6.55 | 4.16 | 7.71 | 6.55 | 7.98 | 8.71 | 9.02 | 7.42 | 7.03 | 6.48 | 6.34 | 4.81 | 6.79 | 3.59 | 4.58 | 4.76 | 4.07 | 8.48 | 5.26 | 6.13 | 6.88 |
| — | -52.2% | -14.5% | -11.8% | +13.4% | +34.3% | +42.4% | +54.1% | +3.6% | +80.4% | +38.3% | +1.2% | +66.8% | -57.6% | -12.9% | -22.4% | -40.9% | +15.0% | -37.1% | -5.2% | -29.8% | |
| Quick Ratio | 6.55 | 4.16 | 7.71 | 6.55 | 7.98 | 8.71 | 9.02 | 7.42 | 7.03 | 6.48 | 6.34 | 4.81 | 6.79 | 3.55 | 4.54 | 4.76 | 4.07 | 8.48 | 5.26 | 6.13 | 6.88 |
| — | -52.2% | -14.5% | -11.8% | +13.4% | +34.3% | +42.4% | +54.1% | +3.6% | +82.6% | +39.5% | +1.2% | +66.8% | -58.1% | -13.6% | -22.4% | -40.9% | +15.0% | -37.1% | -5.2% | -29.8% | |
| Interest Coverage | — | -27.21 | — | — | — | — | — | -6.16 | — | — | — | — | -293.60 | — | — | -12.89 | — | -932.50 | -119.45 | -174.23 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EOCN stock.
Eocene Ltd.'s current P/E is -0.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Eocene Ltd.'s business trajectory between earnings reports.